Global Antibody-oligonucleotide Conjugates (AOCs) Supply, Demand and Key Producers, 2024-2030

Page: 111

Published Date: 11 Oct 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.

The global Antibody-oligonucleotide Conjugates (AOCs) market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Antibody-oligonucleotide Conjugates (AOCs) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antibody-oligonucleotide Conjugates (AOCs) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antibody-oligonucleotide Conjugates (AOCs) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antibody-oligonucleotide Conjugates (AOCs) total production and demand, 2019-2030, (kg)
Global Antibody-oligonucleotide Conjugates (AOCs) total production value, 2019-2030, (USD Million)
Global Antibody-oligonucleotide Conjugates (AOCs) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (kg), (based on production site)
Global Antibody-oligonucleotide Conjugates (AOCs) consumption by region & country, CAGR, 2019-2030 & (kg)
U.S. VS China: Antibody-oligonucleotide Conjugates (AOCs) domestic production, consumption, key domestic manufacturers and share
Global Antibody-oligonucleotide Conjugates (AOCs) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (kg)
Global Antibody-oligonucleotide Conjugates (AOCs) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (kg)
Global Antibody-oligonucleotide Conjugates (AOCs) production by Application, production, value, CAGR, 2019-2030, (USD Million) & (kg)
This report profiles key players in the global Antibody-oligonucleotide Conjugates (AOCs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rockland, BOCSCI Inc., Creative Biolabs, Bio-Synthesis Inc, IntegrateRNA, CellMosaic, Leinco, WuXi XDC, Lonza, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antibody-oligonucleotide Conjugates (AOCs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (kg) and average price (US$/g) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Antibody-oligonucleotide Conjugates (AOCs) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antibody-oligonucleotide Conjugates (AOCs) Market, Segmentation by Type:
    Chemical Coupling
    Enzymatic Coupling

Global Antibody-oligonucleotide Conjugates (AOCs) Market, Segmentation by Application:
    Pharmaceuticals
    Scientific Research

Companies Profiled:
    Rockland
    BOCSCI Inc.
    Creative Biolabs
    Bio-Synthesis Inc
    IntegrateRNA
    CellMosaic
    Leinco
    WuXi XDC
    Lonza

Key Questions Answered:
1. How big is the global Antibody-oligonucleotide Conjugates (AOCs) market?
2. What is the demand of the global Antibody-oligonucleotide Conjugates (AOCs) market?
3. What is the year over year growth of the global Antibody-oligonucleotide Conjugates (AOCs) market?
4. What is the production and production value of the global Antibody-oligonucleotide Conjugates (AOCs) market?
5. Who are the key producers in the global Antibody-oligonucleotide Conjugates (AOCs) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antibody-oligonucleotide Conjugates (AOCs) Introduction
    1.2 World Antibody-oligonucleotide Conjugates (AOCs) Supply & Forecast
        1.2.1 World Antibody-oligonucleotide Conjugates (AOCs) Production Value (2019 & 2023 & 2030)
        1.2.2 World Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030)
        1.2.3 World Antibody-oligonucleotide Conjugates (AOCs) Pricing Trends (2019-2030)
    1.3 World Antibody-oligonucleotide Conjugates (AOCs) Production by Region (Based on Production Site)
        1.3.1 World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Region (2019-2030)
        1.3.2 World Antibody-oligonucleotide Conjugates (AOCs) Production by Region (2019-2030)
        1.3.3 World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Region (2019-2030)
        1.3.4 North America Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030)
        1.3.5 Europe Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030)
        1.3.6 China Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030)
        1.3.7 Japan Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antibody-oligonucleotide Conjugates (AOCs) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antibody-oligonucleotide Conjugates (AOCs) Major Market Trends

2 Demand Summary
    2.1 World Antibody-oligonucleotide Conjugates (AOCs) Demand (2019-2030)
    2.2 World Antibody-oligonucleotide Conjugates (AOCs) Consumption by Region
        2.2.1 World Antibody-oligonucleotide Conjugates (AOCs) Consumption by Region (2019-2024)
        2.2.2 World Antibody-oligonucleotide Conjugates (AOCs) Consumption Forecast by Region (2025-2030)
    2.3 United States Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.4 China Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.5 Europe Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.6 Japan Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.7 South Korea Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.8 ASEAN Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)
    2.9 India Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Manufacturer (2019-2024)
    3.2 World Antibody-oligonucleotide Conjugates (AOCs) Production by Manufacturer (2019-2024)
    3.3 World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Manufacturer (2019-2024)
    3.4 Antibody-oligonucleotide Conjugates (AOCs) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Antibody-oligonucleotide Conjugates (AOCs) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Antibody-oligonucleotide Conjugates (AOCs) in 2023
        3.5.3 Global Concentration Ratios (CR8) for Antibody-oligonucleotide Conjugates (AOCs) in 2023
    3.6 Antibody-oligonucleotide Conjugates (AOCs) Market: Overall Company Footprint Analysis
        3.6.1 Antibody-oligonucleotide Conjugates (AOCs) Market: Region Footprint
        3.6.2 Antibody-oligonucleotide Conjugates (AOCs) Market: Company Product Type Footprint
        3.6.3 Antibody-oligonucleotide Conjugates (AOCs) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Value Comparison
        4.1.1 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Comparison
        4.2.1 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Consumption Comparison
        4.3.1 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2024)
    4.5 China Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers and Market Share
        4.5.1 China Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value (2019-2024)
        4.5.3 China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2024)
    4.6 Rest of World Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2024)

5 Market Analysis by Type
    5.1 World Antibody-oligonucleotide Conjugates (AOCs) Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Chemical Coupling
        5.2.2 Enzymatic Coupling
    5.3 Market Segment by Type
        5.3.1 World Antibody-oligonucleotide Conjugates (AOCs) Production by Type (2019-2030)
        5.3.2 World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Type (2019-2030)
        5.3.3 World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Antibody-oligonucleotide Conjugates (AOCs) Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceuticals
        6.2.2 Scientific Research
    6.3 Market Segment by Application
        6.3.1 World Antibody-oligonucleotide Conjugates (AOCs) Production by Application (2019-2030)
        6.3.2 World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Application (2019-2030)
        6.3.3 World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Rockland
        7.1.1 Rockland Details
        7.1.2 Rockland Major Business
        7.1.3 Rockland Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.1.4 Rockland Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Rockland Recent Developments/Updates
        7.1.6 Rockland Competitive Strengths & Weaknesses
    7.2 BOCSCI Inc.
        7.2.1 BOCSCI Inc. Details
        7.2.2 BOCSCI Inc. Major Business
        7.2.3 BOCSCI Inc. Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.2.4 BOCSCI Inc. Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 BOCSCI Inc. Recent Developments/Updates
        7.2.6 BOCSCI Inc. Competitive Strengths & Weaknesses
    7.3 Creative Biolabs
        7.3.1 Creative Biolabs Details
        7.3.2 Creative Biolabs Major Business
        7.3.3 Creative Biolabs Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.3.4 Creative Biolabs Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Creative Biolabs Recent Developments/Updates
        7.3.6 Creative Biolabs Competitive Strengths & Weaknesses
    7.4 Bio-Synthesis Inc
        7.4.1 Bio-Synthesis Inc Details
        7.4.2 Bio-Synthesis Inc Major Business
        7.4.3 Bio-Synthesis Inc Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.4.4 Bio-Synthesis Inc Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Bio-Synthesis Inc Recent Developments/Updates
        7.4.6 Bio-Synthesis Inc Competitive Strengths & Weaknesses
    7.5 IntegrateRNA
        7.5.1 IntegrateRNA Details
        7.5.2 IntegrateRNA Major Business
        7.5.3 IntegrateRNA Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.5.4 IntegrateRNA Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 IntegrateRNA Recent Developments/Updates
        7.5.6 IntegrateRNA Competitive Strengths & Weaknesses
    7.6 CellMosaic
        7.6.1 CellMosaic Details
        7.6.2 CellMosaic Major Business
        7.6.3 CellMosaic Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.6.4 CellMosaic Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 CellMosaic Recent Developments/Updates
        7.6.6 CellMosaic Competitive Strengths & Weaknesses
    7.7 Leinco
        7.7.1 Leinco Details
        7.7.2 Leinco Major Business
        7.7.3 Leinco Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.7.4 Leinco Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Leinco Recent Developments/Updates
        7.7.6 Leinco Competitive Strengths & Weaknesses
    7.8 WuXi XDC
        7.8.1 WuXi XDC Details
        7.8.2 WuXi XDC Major Business
        7.8.3 WuXi XDC Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.8.4 WuXi XDC Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 WuXi XDC Recent Developments/Updates
        7.8.6 WuXi XDC Competitive Strengths & Weaknesses
    7.9 Lonza
        7.9.1 Lonza Details
        7.9.2 Lonza Major Business
        7.9.3 Lonza Antibody-oligonucleotide Conjugates (AOCs) Product and Services
        7.9.4 Lonza Antibody-oligonucleotide Conjugates (AOCs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Lonza Recent Developments/Updates
        7.9.6 Lonza Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antibody-oligonucleotide Conjugates (AOCs) Industry Chain
    8.2 Antibody-oligonucleotide Conjugates (AOCs) Upstream Analysis
        8.2.1 Antibody-oligonucleotide Conjugates (AOCs) Core Raw Materials
        8.2.2 Main Manufacturers of Antibody-oligonucleotide Conjugates (AOCs) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Antibody-oligonucleotide Conjugates (AOCs) Production Mode
    8.6 Antibody-oligonucleotide Conjugates (AOCs) Procurement Model
    8.7 Antibody-oligonucleotide Conjugates (AOCs) Industry Sales Model and Sales Channels
        8.7.1 Antibody-oligonucleotide Conjugates (AOCs) Sales Model
        8.7.2 Antibody-oligonucleotide Conjugates (AOCs) Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Region (2019-2024)
 Table 5. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Region (2025-2030)
 Table 6. World Antibody-oligonucleotide Conjugates (AOCs) Production by Region (2019-2024) & (kg)
 Table 7. World Antibody-oligonucleotide Conjugates (AOCs) Production by Region (2025-2030) & (kg)
 Table 8. World Antibody-oligonucleotide Conjugates (AOCs) Production Market Share by Region (2019-2024)
 Table 9. World Antibody-oligonucleotide Conjugates (AOCs) Production Market Share by Region (2025-2030)
 Table 10. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Region (2019-2024) & (US$/g)
 Table 11. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Region (2025-2030) & (US$/g)
 Table 12. Antibody-oligonucleotide Conjugates (AOCs) Major Market Trends
 Table 13. World Antibody-oligonucleotide Conjugates (AOCs) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (kg)
 Table 14. World Antibody-oligonucleotide Conjugates (AOCs) Consumption by Region (2019-2024) & (kg)
 Table 15. World Antibody-oligonucleotide Conjugates (AOCs) Consumption Forecast by Region (2025-2030) & (kg)
 Table 16. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Antibody-oligonucleotide Conjugates (AOCs) Producers in 2023
 Table 18. World Antibody-oligonucleotide Conjugates (AOCs) Production by Manufacturer (2019-2024) & (kg)
 Table 19. Production Market Share of Key Antibody-oligonucleotide Conjugates (AOCs) Producers in 2023
 Table 20. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Manufacturer (2019-2024) & (US$/g)
 Table 21. Global Antibody-oligonucleotide Conjugates (AOCs) Company Evaluation Quadrant
 Table 22. World Antibody-oligonucleotide Conjugates (AOCs) Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Antibody-oligonucleotide Conjugates (AOCs) Production Site of Key Manufacturer
 Table 24. Antibody-oligonucleotide Conjugates (AOCs) Market: Company Product Type Footprint
 Table 25. Antibody-oligonucleotide Conjugates (AOCs) Market: Company Product Application Footprint
 Table 26. Antibody-oligonucleotide Conjugates (AOCs) Competitive Factors
 Table 27. Antibody-oligonucleotide Conjugates (AOCs) New Entrant and Capacity Expansion Plans
 Table 28. Antibody-oligonucleotide Conjugates (AOCs) Mergers & Acquisitions Activity
 Table 29. United States VS China Antibody-oligonucleotide Conjugates (AOCs) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Antibody-oligonucleotide Conjugates (AOCs) Production Comparison, (2019 & 2023 & 2030) & (kg)
 Table 31. United States VS China Antibody-oligonucleotide Conjugates (AOCs) Consumption Comparison, (2019 & 2023 & 2030) & (kg)
 Table 32. United States Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2024) & (kg)
 Table 36. United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share (2019-2024)
 Table 37. China Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production, (2019-2024) & (kg)
 Table 41. China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share (2019-2024)
 Table 42. Rest of World Based Antibody-oligonucleotide Conjugates (AOCs) Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production, (2019-2024) & (kg)
 Table 46. Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share (2019-2024)
 Table 47. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Antibody-oligonucleotide Conjugates (AOCs) Production by Type (2019-2024) & (kg)
 Table 49. World Antibody-oligonucleotide Conjugates (AOCs) Production by Type (2025-2030) & (kg)
 Table 50. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Type (2019-2024) & (US$/g)
 Table 53. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Type (2025-2030) & (US$/g)
 Table 54. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Antibody-oligonucleotide Conjugates (AOCs) Production by Application (2019-2024) & (kg)
 Table 56. World Antibody-oligonucleotide Conjugates (AOCs) Production by Application (2025-2030) & (kg)
 Table 57. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Application (2019-2024) & (US$/g)
 Table 60. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Application (2025-2030) & (US$/g)
 Table 61. Rockland Basic Information, Manufacturing Base and Competitors
 Table 62. Rockland Major Business
 Table 63. Rockland Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 64. Rockland Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Rockland Recent Developments/Updates
 Table 66. Rockland Competitive Strengths & Weaknesses
 Table 67. BOCSCI Inc. Basic Information, Manufacturing Base and Competitors
 Table 68. BOCSCI Inc. Major Business
 Table 69. BOCSCI Inc. Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 70. BOCSCI Inc. Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. BOCSCI Inc. Recent Developments/Updates
 Table 72. BOCSCI Inc. Competitive Strengths & Weaknesses
 Table 73. Creative Biolabs Basic Information, Manufacturing Base and Competitors
 Table 74. Creative Biolabs Major Business
 Table 75. Creative Biolabs Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 76. Creative Biolabs Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Creative Biolabs Recent Developments/Updates
 Table 78. Creative Biolabs Competitive Strengths & Weaknesses
 Table 79. Bio-Synthesis Inc Basic Information, Manufacturing Base and Competitors
 Table 80. Bio-Synthesis Inc Major Business
 Table 81. Bio-Synthesis Inc Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 82. Bio-Synthesis Inc Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Bio-Synthesis Inc Recent Developments/Updates
 Table 84. Bio-Synthesis Inc Competitive Strengths & Weaknesses
 Table 85. IntegrateRNA Basic Information, Manufacturing Base and Competitors
 Table 86. IntegrateRNA Major Business
 Table 87. IntegrateRNA Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 88. IntegrateRNA Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. IntegrateRNA Recent Developments/Updates
 Table 90. IntegrateRNA Competitive Strengths & Weaknesses
 Table 91. CellMosaic Basic Information, Manufacturing Base and Competitors
 Table 92. CellMosaic Major Business
 Table 93. CellMosaic Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 94. CellMosaic Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. CellMosaic Recent Developments/Updates
 Table 96. CellMosaic Competitive Strengths & Weaknesses
 Table 97. Leinco Basic Information, Manufacturing Base and Competitors
 Table 98. Leinco Major Business
 Table 99. Leinco Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 100. Leinco Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Leinco Recent Developments/Updates
 Table 102. Leinco Competitive Strengths & Weaknesses
 Table 103. WuXi XDC Basic Information, Manufacturing Base and Competitors
 Table 104. WuXi XDC Major Business
 Table 105. WuXi XDC Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 106. WuXi XDC Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. WuXi XDC Recent Developments/Updates
 Table 108. WuXi XDC Competitive Strengths & Weaknesses
 Table 109. Lonza Basic Information, Manufacturing Base and Competitors
 Table 110. Lonza Major Business
 Table 111. Lonza Antibody-oligonucleotide Conjugates (AOCs) Product and Services
 Table 112. Lonza Antibody-oligonucleotide Conjugates (AOCs) Production (kg), Price (US$/g), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Lonza Recent Developments/Updates
 Table 114. Lonza Competitive Strengths & Weaknesses
 Table 115. Global Key Players of Antibody-oligonucleotide Conjugates (AOCs) Upstream (Raw Materials)
 Table 116. Global Antibody-oligonucleotide Conjugates (AOCs) Typical Customers
 Table 117. Antibody-oligonucleotide Conjugates (AOCs) Typical Distributors


List of Figures
 Figure 1. Antibody-oligonucleotide Conjugates (AOCs) Picture
 Figure 2. World Antibody-oligonucleotide Conjugates (AOCs) Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Antibody-oligonucleotide Conjugates (AOCs) Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030) & (kg)
 Figure 5. World Antibody-oligonucleotide Conjugates (AOCs) Average Price (2019-2030) & (US$/g)
 Figure 6. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Region (2019-2030)
 Figure 7. World Antibody-oligonucleotide Conjugates (AOCs) Production Market Share by Region (2019-2030)
 Figure 8. North America Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030) & (kg)
 Figure 9. Europe Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030) & (kg)
 Figure 10. China Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030) & (kg)
 Figure 11. Japan Antibody-oligonucleotide Conjugates (AOCs) Production (2019-2030) & (kg)
 Figure 12. Antibody-oligonucleotide Conjugates (AOCs) Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 15. World Antibody-oligonucleotide Conjugates (AOCs) Consumption Market Share by Region (2019-2030)
 Figure 16. United States Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 17. China Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 18. Europe Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 19. Japan Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 20. South Korea Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 21. ASEAN Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 22. India Antibody-oligonucleotide Conjugates (AOCs) Consumption (2019-2030) & (kg)
 Figure 23. Producer Shipments of Antibody-oligonucleotide Conjugates (AOCs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Antibody-oligonucleotide Conjugates (AOCs) Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Antibody-oligonucleotide Conjugates (AOCs) Markets in 2023
 Figure 26. United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Antibody-oligonucleotide Conjugates (AOCs) Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share 2023
 Figure 30. China Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Antibody-oligonucleotide Conjugates (AOCs) Production Market Share 2023
 Figure 32. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Type in 2023
 Figure 34. Chemical Coupling
 Figure 35. Enzymatic Coupling
 Figure 36. World Antibody-oligonucleotide Conjugates (AOCs) Production Market Share by Type (2019-2030)
 Figure 37. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Type (2019-2030)
 Figure 38. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Type (2019-2030) & (US$/g)
 Figure 39. World Antibody-oligonucleotide Conjugates (AOCs) Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Application in 2023
 Figure 41. Pharmaceuticals
 Figure 42. Scientific Research
 Figure 43. World Antibody-oligonucleotide Conjugates (AOCs) Production Market Share by Application (2019-2030)
 Figure 44. World Antibody-oligonucleotide Conjugates (AOCs) Production Value Market Share by Application (2019-2030)
 Figure 45. World Antibody-oligonucleotide Conjugates (AOCs) Average Price by Application (2019-2030) & (US$/g)
 Figure 46. Antibody-oligonucleotide Conjugates (AOCs) Industry Chain
 Figure 47. Antibody-oligonucleotide Conjugates (AOCs) Procurement Model
 Figure 48. Antibody-oligonucleotide Conjugates (AOCs) Sales Model
 Figure 49. Antibody-oligonucleotide Conjugates (AOCs) Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Rockland
BOCSCI Inc.
Creative Biolabs
Bio-Synthesis Inc
IntegrateRNA
CellMosaic
Leinco
WuXi XDC
Lonza

Related Reports

Global Antibody-oligonucleotide Conjugates (AOCs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antibody-oligonucleotide Conjugates (AOCs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Oct 2024

date Chemical & Material

Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.

Product Tags

Antibody-oligonucleotide Conjugates (AOCs)

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>